Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants

{ 'indexed': {'date-parts': [[2024, 3, 8]], 'date-time': '2024-03-08T02:03:01Z', 'timestamp': 1709863381479}, 'reference-count': 45, 'publisher': 'Elsevier BV', 'issue': '4', 'license': [ { 'start': { 'date-parts': [[2020, 10, 1]], 'date-time': '2020-10-01T00:00:00Z', 'timestamp': 1601510400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'funder': [ { 'DOI': '10.13039/501100003441', 'name': 'Universitair Ziekenhuis Gent', 'doi-asserted-by': 'publisher', 'award': ['BC-07507']}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 10]]}, 'DOI': '10.1016/j.ijantimicag.2020.106144', 'type': 'journal-article', 'created': {'date-parts': [[2020, 8, 24]], 'date-time': '2020-08-24T15:36:25Z', 'timestamp': 1598283385000}, 'page': '106144', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 96, 'title': 'Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a ' 'nationwide observational study of 8075 participants', 'prefix': '10.1016', 'volume': '56', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-4695-4275', 'authenticated-orcid': False, 'given': 'Lucy', 'family': 'Catteau', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-7697-6849', 'authenticated-orcid': False, 'given': 'Nicolas', 'family': 'Dauby', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marion', 'family': 'Montourcy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emmanuel', 'family': 'Bottieau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joris', 'family': 'Hautekiet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Els', 'family': 'Goetghebeur', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sabrina', 'family': 'van Ierssel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Els', 'family': 'Duysburgh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Herman', 'family': 'Van Oyen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chloé', 'family': 'Wyndham-Thomas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dominique', 'family': 'Van Beckhoven', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kristof', 'family': 'Bafort', 'sequence': 'additional', 'affiliation': []}, {'given': 'Leïla', 'family': 'Belkhir', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nathalie', 'family': 'Bossuyt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Caprasse', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vincent', 'family': 'Colombie', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'De Munter', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jessika', 'family': 'Deblonde', 'sequence': 'additional', 'affiliation': []}, {'given': 'Didier', 'family': 'Delmarcelle', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mélanie', 'family': 'Delvallee', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rémy', 'family': 'Demeester', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thierry', 'family': 'Dugernier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xavier', 'family': 'Holemans', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benjamin', 'family': 'Kerzmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pierre', 'family': 'Yves Machurot', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Minette', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-Marc', 'family': 'Minon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Saphia', 'family': 'Mokrane', 'sequence': 'additional', 'affiliation': []}, {'given': 'Catherine', 'family': 'Nachtergal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Séverine', 'family': 'Noirhomme', 'sequence': 'additional', 'affiliation': []}, {'given': 'Denis', 'family': 'Piérard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Camelia', 'family': 'Rossi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carole', 'family': 'Schirvel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Erica', 'family': 'Sermijn', 'sequence': 'additional', 'affiliation': []}, {'given': 'Frank', 'family': 'Staelens', 'sequence': 'additional', 'affiliation': []}, {'given': 'Filip', 'family': 'Triest', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nina Van', 'family': 'Goethem', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jens Van', 'family': 'Praet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anke', 'family': 'Vanhoenacker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Roeland', 'family': 'Verstraete', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elise', 'family': 'Willems', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.ijantimicag.2020.106144_bib0001', 'doi-asserted-by': 'crossref', 'first-page': '264', 'DOI': '10.1016/j.bbrc.2004.08.085', 'article-title': 'In vitro inhibition of severe acute respiratory syndrome coronavirus by ' 'chloroquine', 'volume': '323', 'author': 'Keyaerts', 'year': '2004', 'journal-title': 'Biochem Biophys Res Commun'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0002', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.1186/1743-422X-2-69', 'article-title': 'Chloroquine is a potent inhibitor of SARS coronavirus infection and ' 'spread', 'volume': '2', 'author': 'Vincent', 'year': '2005', 'journal-title': 'Virol J'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0003', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0004', 'doi-asserted-by': 'crossref', 'first-page': '16', 'DOI': '10.1038/s41421-020-0156-0', 'article-title': 'Hydroxychloroquine, a less toxic derivative of chloroquine, is ' 'effective in inhibiting SARS-CoV-2 infection in vitro', 'volume': '6', 'author': 'Liu', 'year': '2020', 'journal-title': 'Cell Discov'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0005', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/cid/ciaa546', 'article-title': 'Chloroquine inhibits the release of inflammatory cytokines by human ' 'lung explants', 'author': 'Grassin-Delyle', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0006', 'doi-asserted-by': 'crossref', 'first-page': '910', 'DOI': '10.1016/j.immuni.2020.05.002', 'article-title': 'Immunology of COVID-19: current state of the science', 'volume': '52', 'author': 'Vabret', 'year': '2020', 'journal-title': 'Immunity'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0007', 'doi-asserted-by': 'crossref', 'first-page': '155', 'DOI': '10.1038/s41584-020-0372-x', 'article-title': 'Mechanisms of action of hydroxychloroquine and chloroquine: ' 'implications for rheumatology', 'volume': '16', 'author': 'Schrezenmeier', 'year': '2020', 'journal-title': 'Nat Rev Rheumatol'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0008', 'unstructured': 'Sciensano Interim clinical guidance for adults with suspected or ' 'confirmed COVID-19 in Belgium. Sciensano; 2020. ' 'https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_InterimGuidelines_Treatment_ENG.pdf.'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0009', 'doi-asserted-by': 'crossref', 'first-page': '732', 'DOI': '10.1093/cid/ciaa237', 'article-title': 'In vitro antiviral activity and projection of optimized dosing design ' 'of hydroxychloroquine for the treatment of severe acute respiratory ' 'syndrome coronavirus 2 (SARS-CoV-2)', 'volume': '71', 'author': 'Yao', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0010', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/cid/ciaa394', 'article-title': 'Towards optimization of hydroxychloroquine dosing in intensive care ' 'unit COVID-19 patients', 'author': 'Perinel', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '2411', 'DOI': '10.1056/NEJMoa2012410', 'article-title': 'Observational study of hydroxychloroquine in hospitalized patients with ' 'COVID-19', 'volume': '382', 'author': 'Geleris', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0012', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'volume': '56', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0013', 'doi-asserted-by': 'crossref', 'first-page': 'm1844', 'DOI': '10.1136/bmj.m1844', 'article-title': 'Clinical efficacy of hydroxychloroquine in patients with COVID-19 ' 'pneumonia who require oxygen: observational comparative study using ' 'routine care data', 'volume': '369', 'author': 'Mahévas', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '2493', 'DOI': '10.1001/jama.2020.8630', 'article-title': 'Association of treatment with hydroxychloroquine or azithromycin with ' 'in-hospital mortality in patients with COVID-19 in New York State', 'volume': '323', 'author': 'Rosenberg', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0015', 'first-page': '2493', 'article-title': 'Compassionate use of hydroxychloroquine in clinical practice for ' 'patients with mild to severe COVID-19 in a French university hospital', 'volume': '323', 'author': 'Paccoud', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0016', 'article-title': 'Hydroxychloroquine with or without azithromycin and in-hospital ' 'mortality or discharge in patients hospitalized for COVID-19 infection: ' 'a cohort study of 4,642 in-patients in France', 'author': 'Sbidian', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0017', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.tmaid.2020.101791', 'article-title': 'Outcomes of 3,737 COVID-19 patients treated with ' 'hydroxychloroquine/azithromycin and other regimens in Marseille, ' 'France: a retrospective analysis', 'volume': '36', 'author': 'Lagier', 'year': '2020', 'journal-title': 'Travel Med Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0018', 'doi-asserted-by': 'crossref', 'DOI': '10.1007/s11606-020-05983-z', 'article-title': 'Risk factors for mortality in patients with COVID-19 in New York City', 'author': 'Mikami', 'year': '2020', 'journal-title': 'J Gen Intern Med'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0019', 'doi-asserted-by': 'crossref', 'first-page': '396', 'DOI': '10.1016/j.ijid.2020.06.099', 'article-title': 'Treatment with hydroxychloroquine, azithromycin, and combination in ' 'patients hospitalized with COVID-19', 'volume': '97', 'author': 'Arshad', 'year': '2020', 'journal-title': 'Int J Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0020', 'article-title': 'Effect of hydroxychloroquine in hospitalized patients with COVID-19: ' 'preliminary results from a multi-centre, randomized, controlled trial', 'author': 'Horby', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0021', 'doi-asserted-by': 'crossref', 'first-page': '225', 'DOI': '10.3389/fmed.2020.00225', 'article-title': 'Development and potential usefulness of the COVID-19 Ag Respi-Strip ' 'diagnostic assay in a pandemic context', 'volume': '7', 'author': 'Mertens', 'year': '2020', 'journal-title': 'Front Med'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0022', 'first-page': '1', 'article-title': 'mice: Multivariate Imputation by Chained Equations in R', 'volume': '45', 'author': 'van Buuren', 'year': '2011', 'journal-title': 'J Stat Softw'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0023', 'article-title': 'ipw\xa0: an R package for inverse probability weighting', 'volume': '43', 'author': 'van der Wal', 'year': '2011', 'journal-title': 'J Stat Softw'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0024', 'doi-asserted-by': 'crossref', 'first-page': '1103', 'DOI': '10.1002/sim.6777', 'article-title': 'Comparisons of the performance of different statistical tests for ' 'time-to-event analysis with confounding factors: practical ' 'illustrations in kidney transplantation', 'volume': '35', 'author': 'Le Borgne', 'year': '2016', 'journal-title': 'Stat Med'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0025', 'series-title': 'COVID-19 — Bulletin épidémiologique du 25 mai 2020', 'author': 'Sciensano', 'year': '2020'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0026', 'doi-asserted-by': 'crossref', 'first-page': 'm1985', 'DOI': '10.1136/bmj.m1985', 'article-title': 'Features of 20 133 UK patients in hospital with COVID-19 using the ' 'ISARIC WHO Clinical Characterisation Protocol: prospective ' 'observational cohort study', 'volume': '369', 'author': 'Docherty', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0027', 'doi-asserted-by': 'crossref', 'first-page': '2052', 'DOI': '10.1001/jama.2020.6775', 'article-title': 'Presenting characteristics, comorbidities, and outcomes among 5700 ' 'patients hospitalized with COVID-19 in the New York City area', 'volume': '323', 'author': 'Richardson', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0028', 'article-title': 'Dexamethasone in hospitalized patients with COVID-19—preliminary report', 'author': 'Horby', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0029', 'doi-asserted-by': 'crossref', 'first-page': '1054', 'DOI': '10.1016/S0140-6736(20)30566-3', 'article-title': 'Clinical course and risk factors for mortality of adult inpatients with ' 'COVID-19 in Wuhan, China: a retrospective cohort study', 'volume': '395', 'author': 'Zhou', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0030', 'doi-asserted-by': 'crossref', 'first-page': '1089', 'DOI': '10.1007/s00134-020-06062-x', 'article-title': 'High risk of thrombosis in patients with severe SARS-CoV-2 infection: a ' 'multicenter prospective cohort study', 'volume': '46', 'author': 'Helms', 'year': '2020', 'journal-title': 'Intensive Care Med'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0031', 'doi-asserted-by': 'crossref', 'first-page': '876', 'DOI': '10.1055/s-0040-1709650', 'article-title': 'D-dimer is associated with severity of coronavirus disease 2019: a ' 'pooled analysis', 'volume': '120', 'author': 'Lippi', 'year': '2020', 'journal-title': 'Thromb Haemost'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0032', 'doi-asserted-by': 'crossref', 'first-page': '216', 'DOI': '10.1016/j.ijid.2020.06.095', 'article-title': 'An observational cohort study of hydroxychloroquine and azithromycin ' "for COVID-19: (can't get no) satisfaction", 'volume': '98', 'author': 'Lee', 'year': '2020', 'journal-title': 'Int J Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0033', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.antiviral.2020.104762', 'article-title': 'Of chloroquine and COVID-19', 'volume': '177', 'author': 'Touret', 'year': '2020', 'journal-title': 'Antiviral Res'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0034', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/cid/ciaa623', 'article-title': 'Connecting hydroxychloroquine in vitro antiviral activity to in vivo ' 'concentration for prediction of antiviral effect: a critical step in ' 'treating COVID-19 patients', 'author': 'Fan', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0035', 'article-title': 'Hydroxychloroquine in COVID-19 patients: what still needs to be known ' 'about the kinetics', 'author': 'Martin-Blondel', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0036', 'article-title': 'Antiviral treatment of SARS-CoV-2-infected hamsters reveals a weak ' 'effect of favipiravir and a complete lack of effect for ' 'hydroxychloroquine', 'author': 'Kaptein', 'year': '2020', 'journal-title': 'bioRxiv'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0037', 'doi-asserted-by': 'crossref', 'DOI': '10.1038/s41586-020-2558-4', 'article-title': 'Hydroxychloroquine in the treatment and prophylaxis of SARS-CoV-2 ' 'infection in non-human primates', 'author': 'Maisonnasse', 'year': '2020', 'journal-title': 'Nature'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0038', 'doi-asserted-by': 'crossref', 'first-page': '363', 'DOI': '10.1038/s41577-020-0311-8', 'article-title': 'The trinity of COVID-19: immunity, inflammation and intervention', 'volume': '20', 'author': 'Tay', 'year': '2020', 'journal-title': 'Nat Rev Immunol'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0039', 'doi-asserted-by': 'crossref', 'first-page': '703', 'DOI': '10.1093/rheumatology/kei282', 'article-title': 'Chloroquine inhibits production of TNF-α, IL-1β and IL-6 from ' 'lipopolysaccharide-stimulated human monocytes/macrophages by different ' 'modes', 'volume': '45', 'author': 'Jang', 'year': '2006', 'journal-title': 'Rheumatology'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0040', 'doi-asserted-by': 'crossref', 'first-page': '766', 'DOI': '10.6061/clinics/2013(06)07', 'article-title': 'Hydroxychloroquine decreases Th17-related cytokines in systemic lupus ' 'erythematosus and rheumatoid arthritis patients', 'volume': '68', 'author': 'Silva', 'year': '2013', 'journal-title': 'Clinics (Sao Paulo)'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0041', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.106078', 'article-title': 'A pharmacological perspective of chloroquine in SARS-CoV-2 infection', 'author': 'Oscanoa', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0042', 'doi-asserted-by': 'crossref', 'first-page': '160', 'DOI': '10.1038/d41586-020-01695-w', 'article-title': 'High-profile coronavirus retractions raise concerns about data ' 'oversight', 'volume': '582', 'author': 'Ledford', 'year': '2020', 'journal-title': 'Nature'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0043', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jamanetworkopen.2020.8857', 'article-title': 'Effect of high vs low doses of chloroquine diphosphate as adjunctive ' 'therapy for patients hospitalized with severe acute respiratory ' 'syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical ' 'trial', 'volume': '3', 'author': 'Borba', 'year': '2020', 'journal-title': 'JAMA Netw Open'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0044', 'article-title': 'Safety of hydroxychloroquine, alone and in combination with ' 'azithromycin, in light of rapid wide-spread use for COVID-19: a ' 'multinational, network cohort and self-controlled case series study', 'author': 'Lane', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': '10.1016/j.ijantimicag.2020.106144_bib0045', 'series-title': 'Summary adverse drug reactions in corona virus infection', 'year': '2020'}], 'container-title': 'International Journal of Antimicrobial Agents', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920303423?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920303423?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2021, 1, 14]], 'date-time': '2021-01-14T23:44:24Z', 'timestamp': 1610667864000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0924857920303423'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 10]]}, 'references-count': 45, 'journal-issue': {'issue': '4', 'published-print': {'date-parts': [[2020, 10]]}}, 'alternative-id': ['S0924857920303423'], 'URL': 'http://dx.doi.org/10.1016/j.ijantimicag.2020.106144', 'relation': {}, 'ISSN': ['0924-8579'], 'subject': ['Pharmacology (medical)', 'Infectious Diseases', 'Microbiology (medical)', 'General Medicine'], 'container-title-short': 'International Journal of Antimicrobial Agents', 'published': {'date-parts': [[2020, 10]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with ' 'COVID-19: a nationwide observational study of 8075 participants', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'International Journal of Antimicrobial Agents', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ijantimicag.2020.106144', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. ' 'All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '106144'}